Selective androgen receptor modulation for muscle weakness in chronic obstructive pulmonary disease: a randomised control trial

Conclusions GSK2881078 was well tolerated and short-term treatment increased leg strength, when expressed as per cent predicted, in men with COPD more than physical training alone. Trial registration number NCT03359473.

http://thorax.bmj.com/cgi/content/short/78/3/258?rss=1

Source: Thorax - February 16, 2023 Category: Respiratory Medicine Authors: Mohan, D., Rossiter, H., Watz, H., Fogarty, C., Evans, R. A., Man, W., Tabberer, M., Beerahee, M., Kumar, S., Millns, H., Thomas, S., Tal-Singer, R., Russell, A. J., Holland, M. C., Akinseye, C., Neil, D., Polkey, M. I. Tags: Open access, Thorax Skeletal muscle Source Type: research